Mark Johnson | VP, IR |
Stephen Davis | CEO & Director |
Brendan Teehan | EVP, COO & Head, Commercial |
Mark Schneyer | EVP & CFO |
Srdjan Stankovic | President |
Neena Bitritto-Garg | Citigroup |
Tazeen Ahmad | Bank of America Merrill Lynch |
Cory Kasimov | JPMorgan Chase & Co. |
Ritu Baral | Cowen and Company |
Jeff Hung | Morgan Stanley |
Marc Goodman | SVB Leerink |
Matthew Nirenberg | Oppenheimer |
Ami Fadia | Needham & Company |
Alexander Thompson | Stifel, Nicolaus & Company |
Gregory Renza | RBC Capital Markets |
Jason Butler | JMP Securities |
Good day, ladies and gentlemen, and welcome to ACADIA Pharmaceuticals Fourth Quarter and Full Year 2021 Financial Results Conference Call. My name is Gigi, and I will be your coordinator for today. [Operator Instructions]. I would now like to turn the presentation over to Mark Johnson, Vice President of Investor Relations at ACADIA. Please proceed.